FIND is pleased to announce the appointment of Dr Rangarajan Sampath to the position of Chief Scientific Officer. Dr Sampath leads FIND’s R&D and clinical departments and will contribute to shaping and implementing the organization’s portfolio strategies.
As Chief Scientific Officer, Dr Sampath is a key member of FIND’s Executive Management team, which defines the overall business strategy and direction of the organization, mobilizing resources to enable the implementation of FIND’s mission. In this role, Dr Sampath supports the team in identifying, building and managing R&D partnerships.
“We are extremely pleased and fortunate to welcome Ranga to our team, as he brings extensive R&D and portfolio management experience to FIND,” said Catharina Boehme, CEO, FIND. “His knowledge and expertise in infectious disease diagnostics, particularly in areas of fever and antimicrobial resistance, are crucial in addressing global health needs.”
Dr Sampath is the co-founder of Ibis Biosciences and a co-inventor of the IRIDICA (CE-IVD) infectious disease diagnostics platform. Most recently, Dr Sampath served as a Volwiler Senior Research Fellow and Senior Director of R&D for the Ibis Division of Abbott. He led Ibis’ efforts in infectious disease diagnostics, antimicrobial resistance diagnostics and surveillance and was responsible for applications development, validation, data analysis and reporting and scientific research for the Ibis PCR/ESI-MS based IRIDICA platform.
Visit the FIND team page for full biographies.